Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives
Authors
Giorgia Meineri
Department of Veterinary Sciences, School of Agriculture and Veterinary Medicine, University of Turin, 10095 Grugliasco, TO, Italy; [email protected] (G.M.); [email protected] (V.S.); [email protected] (D.A.)
Elisa Martello
Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham NG5 1PB, UK
Elisabetta Radice
Department of Surgical Sciences, Medical School, University of Turin, 10124 Turin, TO, Italy; [email protected]
Vittorio Saettone
Department of Veterinary Sciences, School of Agriculture and Veterinary Medicine, University of Turin, 10095 Grugliasco, TO, Italy; [email protected] (G.M.); [email protected] (V.S.); [email protected] (D.A.)
David Atuahene
Department of Veterinary Sciences, School of Agriculture and Veterinary Medicine, University of Turin, 10095 Grugliasco, TO, Italy; [email protected] (G.M.); [email protected] (V.S.); [email protected] (D.A.)
Simple Summary
Chronic disorders of the intestinal tract (CID) are characterized by signs of inflammation of the intestine for a period of at least three weeks. Both humans and pets can be affected by these disorders. Different therapeutic approaches can be selected to treat patients and the use of natural products has been increased in the last decade, since oxidative stress plays a key role in the progression of the chronic intestinal disorders. In this review, the antioxidant proprieties of several natural products with potential for treatment of CID in human and veterinary medicine are highlighted. Unfortunately, few clinical trials report the use of these products for treating CID in humans and none in animals.
Chronic intestinal disorders (CID) are characterized by persistent, or recurrent gastrointestinal (GI) signs present for at least three weeks. In human medicine, inflammatory bowel disease (IBD) is a group of chronic GI diseases and includes Crohn’s disease (CD) and ulcerative colitis (UC). On the other hand, the general term chronic enteropathies (CE) is preferred in veterinary medicine. Different therapeutic approaches to these diseases are used in both humans and pets. This review is focused on the use of traditional therapies and nutraceuticals with specific antioxidant properties, for the treatment of CID in humans and animal patients. There is strong evidence of the antioxidant properties of the nutraceuticals included in this review, but few studies report their use for treating CID in humans and none in animals. Despite this fact, the majority of the nutraceuticals described in the present article could be considered as promising alternatives for the regular treatment of CID in human and veterinary medicine.
Keywords: inflammatory bowel disease, ulcerative colitis, chronic enteropathies, phytocomplex, trace elements, vitamins, nutraceuticals
Click on "Archives" to access the full archive of scientific preprints. You may use the categories and the search functionality to find select preprints you're interested in.
